888集团(中国)电子游戏有限公司
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
旧版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
2024-02-19
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
2024-02-01
Overseas Regulatory Announcement-Announcement on Memantine Hydrochloride Tablets
2024-01-19
Next Day Disclosure Return
2024-01-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
2024-01-02
List of Directors And Their Roles And Functions
2023-12-22
Renewal of Continuing Connected Transaction In Relation To Trademark Licence Agr
2023-12-22
Poll Results of the General Meeting And Re-election of Directors And Supervisors; Members of The Board Committees;And Re-Appointment of Senior Management
2023-12-22
Overseas Regulatory Announcement-Announcement on Levamlodiping Besylate Tablets
2023-12-13
Overseas Regulatory Announcement-Announcement on Cefixime Capsules Passing the G
2023-12-04
<
...
4
5
6
7
8
9
10
...
>